122 related articles for article (PubMed ID: 29798336)
21. The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis.
Song JH; Wu HG; Keam BS; Hah JH; Ahn YC; Oh D; Noh JM; Park HJ; Lee CG; Keum KC; Cha J; Cho KH; Moon SH; Kim JY; Chung WK; Oh YT; Kim WT; Cho MJ; Kay CS; Kim YS
Cancer Res Treat; 2016 Jul; 48(3):917-27. PubMed ID: 26727716
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
[TBL] [Abstract][Full Text] [Related]
23. A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.
Lee AWM; Tung SY; Ng WT; Lee V; Ngan RKC; Choi HCW; Chan LLK; Siu LL; Ng AWY; Leung TW; Yiu HHY; O'Sullivan B; Chappell R
Cancer; 2017 Nov; 123(21):4147-4157. PubMed ID: 28662313
[TBL] [Abstract][Full Text] [Related]
24. Combined radiotherapy and chemotherapy in stage T3 and T4 nasopharyngeal carcinoma in children.
Gasparini M; Lombardi F; Rottoli L; Ballerini E; Morandi F
J Clin Oncol; 1988 Mar; 6(3):491-4. PubMed ID: 3351559
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcomes of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma treated with IMRT: a retrospective study.
Su Z; Mao YP; Tang J; Lan XW; OuYang PY; Xie FY
Tumour Biol; 2016 Apr; 37(4):4429-38. PubMed ID: 26499947
[TBL] [Abstract][Full Text] [Related]
26. A meta-analysis of neoadjuvant chemotherapy plus radiation in the treatment of locally advanced nasopharyngeal carcinoma.
He X; Xu K; Guo J; Zhu Y; Liang X; Liu L
J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C205-8. PubMed ID: 26506877
[TBL] [Abstract][Full Text] [Related]
27. IMRT combined with concurrent chemotherapy plus adjuvant chemotherapy versus IMRT combined with concurrent chemotherapy alone in patients with nasopharyngeal carcinoma.
Zhong Q; Zhu X; Li L; Qu S; Liang Z; Zeng F; Pan X
Oncotarget; 2017 Jun; 8(24):39683-39694. PubMed ID: 28147309
[TBL] [Abstract][Full Text] [Related]
28. [Phase II clinical trial of two different modes of administration of the induction chemotherapy for locally advanced nasopharyngeal carcinoma].
Bi T; Jin F; Wu W; Long J; Li Y; Gong X; Luo X; Li Z; He Q; Qu B
Zhonghua Zhong Liu Za Zhi; 2015 Sep; 37(9):676-81. PubMed ID: 26813432
[TBL] [Abstract][Full Text] [Related]
29. Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects.
Orbach D; Brisse H; Helfre S; Klijanienko J; Bours D; Mosseri V; Rodriguez J
Pediatr Blood Cancer; 2008 Apr; 50(4):849-53. PubMed ID: 17973328
[TBL] [Abstract][Full Text] [Related]
30. Cetuximab or nimotuzumab plus intensity-modulated radiotherapy versus cisplatin plus intensity-modulated radiotherapy for stage II-IVb nasopharyngeal carcinoma.
You R; Sun R; Hua YJ; Li CF; Li JB; Zou X; Yang Q; Liu YP; Zhang YN; Yu T; Cao JY; Zhang MX; Jiang R; Mo HY; Guo L; Cao KJ; Lin AH; Qian CN; Sun Y; Ma J; Chen MY
Int J Cancer; 2017 Sep; 141(6):1265-1276. PubMed ID: 28577306
[TBL] [Abstract][Full Text] [Related]
31. Nasopharyngeal carcinoma: the Dana-Farber Cancer Institute experience with 24 patients treated with induction chemotherapy and radiotherapy.
Clark JR; Norris CM; Dreyfuss AI; Fallon BG; Balogh K; Anderson RF; Chaffey JT; Andersen JW; Miller D
Ann Otol Rhinol Laryngol; 1987; 96(5):608-14. PubMed ID: 3674660
[TBL] [Abstract][Full Text] [Related]
32. Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma.
Wolden SL; Zelefsky MJ; Kraus DH; Rosenzweig KE; Chong LM; Shaha AR; Zhang H; Harrison LB; Shah JP; Pfister DG
J Clin Oncol; 2001 Feb; 19(4):1105-10. PubMed ID: 11181675
[TBL] [Abstract][Full Text] [Related]
33. Weekly cetuximab concurrent with IMRT aggravated radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma: Results of a randomized phase II study.
Xu T; Liu Y; Dou S; Li F; Guan X; Zhu G
Oral Oncol; 2015 Sep; 51(9):875-9. PubMed ID: 26163437
[TBL] [Abstract][Full Text] [Related]
34. Cetuximab in combination with chemoradiation after induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma: preliminary results.
He X; Xu J; Guo W; Jiang X; Wang X; Zong D
Future Oncol; 2013 Oct; 9(10):1459-67. PubMed ID: 24106897
[TBL] [Abstract][Full Text] [Related]
35. Expression of excision repair cross-complementation group 1 in locoregionally advanced nasopharyngeal carcinoma treated with cisplatin-based induction chemotherapy.
Shen C; Chen L; Fu J; Lin H
J Cancer Res Ther; 2016 Oct; 12(Supplement):72-75. PubMed ID: 27721259
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.
Ke LR; Xia WX; Qiu WZ; Huang XJ; Yang J; Yu YH; Liang H; Liu GY; Ye YF; Xiang YQ; Guo X; Lv X
BMC Cancer; 2017 Feb; 17(1):134. PubMed ID: 28202000
[TBL] [Abstract][Full Text] [Related]
37. Nasopharyngeal carcinoma: results of treatment by radiotherapy vs chemotherapy plus radiotherapy.
Kraiphibul P; Atichartakarn V; Clongsusuek P; Kulapaditharom B; Ratanatharathorn V; Isarangkul W
J Med Assoc Thai; 1991 Sep; 74(9):391-6. PubMed ID: 1791393
[TBL] [Abstract][Full Text] [Related]
38. [Therapeutic effect of medical therapy upon undifferentiated nasopharyngeal carcinoma: analysis of 149 cases].
Chen M; Lin S; Zheng W
Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1488-9. PubMed ID: 16200771
[TBL] [Abstract][Full Text] [Related]
39. A retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma.
Li HM; Li P; Qian YJ; Wu X; Xie L; Wang F; Zhang H; Liu L
BMC Cancer; 2016 Dec; 16(1):946. PubMed ID: 27955638
[TBL] [Abstract][Full Text] [Related]
40. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma.
Ma J; Mai HQ; Hong MH; Min HQ; Mao ZD; Cui NJ; Lu TX; Mo HY
J Clin Oncol; 2001 Mar; 19(5):1350-7. PubMed ID: 11230478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]